Thermo Scientific rDNase I is produced through a process that contains no animal by-products. The enzyme is provided free from any detectable RNase activity or animal derivatives. rDNase I has a molecular weight of approximately 30kDa. As an endodeoxyribonuclease, DNase I hydrolyses phosphodiester linkages yielding di-, tri-, and oligonucleotides with a 5' phosphate and a free 3' hydroxyl. DNase I has been shown to act on sing…
Economical, high efficiency columns to purify and/or characterize proteins, peptides, and other biomolecules including antibodies, aggregates, and PEGylated proteinsHigh performance: Analytical and preparative BioSep columns offer high resolution, maximum efficiency, and exceptional peak asymmetryImproved recovery: Extremely inert media offers advantages for accurte quantitationFlexible method development: 3 phases options (20…
Find out how using the right tools can help address the biggest challenges in the world of molecular diagnostics
Discover how molecular virologists are making strides in SARS-CoV-2 research, and the technology that powers their research
Originally published in 1991 by Jancarik & Kim from conditions found to be successful in the crystallization of biological macromolecules. This classic standard sparse matrix screen lets you: Determine initial crystallization conditions. Establish the solubility of a macromolecule in a varying range of pH and precipitants. and with the enhanced buffer selection enables screening of greater crystallization space.Structure Scre…
The Crystal Screen and Crystal Screen 2 reagent kits are designed to provide a highly effective and rapid screening method for the crystallization of macromolecules. The screens are simple and practical for finding initial crystallization conditions. The initial crystallization conditions for more than 1,000 proteins, peptides, oligonucleotides, and small molecules have been determined using Crystal Screen.A highly effective…
Discover the latest in CRISPRi screening, iPSC editing and the latest in molecular diagnostics made possible with gene editing technology
Watch this on-demand webinar to find out about molecular fingerprinting, the A-TEEM fingerprint technique and fluorescence EEM applications
The company aims to ramp up its production capacity of more than 50 million antibody tests per month
The new test would bring disease and antibiotic resistance testing for potential “superbug”
Early identification of the disease will allow specific and extremely effective therapies for the treatment of patients
A Mass-Spectrometry-Based Metabolic Phenotyping Strategy to Investigate the Molecular Response to Ionizing Radiation
Designed to revolutionize the clinical laboratory with streamlined workflow for improved productivity
